Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: A multicenter retrospective study of inpatients, 2009-2011

  • We used the Premier database to determine Clostridium difficile-associated diarrhea burden on U.S. acute care hospitals.
  • Patients with Clostridium difficile-associated diarrhea had higher lengths of stay, intensive care unit admission, and inpatient mortality.
  • Clostridium difficile-associated diarrhea also conferred higher adjusted costs and all-cause readmissions.
  • Clostridium difficile-associated diarrhea-attributable costs and readmissions were also higher in high-risk subgroups.
  • Prevention of initial and recurrent Clostridium difficile-associated diarrhea is essential to lessen burden to hospitals.

Authors: Glenn Magee, MBA, Marcie E. Strauss, MPH,  Sheila M. Thomas, PharmD2,  Harold Brown, MHA, MBA, Dorothy Baumer, MS,  Kelly C. Broderick, PharmD

Leave a comment